Hengrui Medicine’s revenue in the first quarter was 5.479 billion yuan and another 1.007 billion yuan was invested in innovative research and development – yqqlm

  • Post date April 22, 2022 — 22:03 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

000925 Jiangsu Hengrui Medicine Jiangsu Lianyungang Port Shanghai Pharmaceuticals Holding Unittec Science, Technology Society Management Strategy, Marketing Annual, Special Corporate Meeting Research, Development Pharmaceutical Market, Exchange Cancer Epidemic Hospital Medicine Ceremony Club, Association Food, Drink Enthusiasm House, Home Food, Drink Regulations Pharmacology Welfare Charity Small, Medium Enterprise Oncology

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data